Heritage (HRTG) files Form 144 for 25,000 vested shares sale

Rhea-AI Filing Summary

Heritage Insurance Holdings, Inc. (HRTG) filed a Form 144 reporting a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of $614,250 and shows approximately 31,017,570 shares outstanding, indicating the proposed sale represents about 0.08% of the outstanding common stock. The shares were acquired on 11/04/2023 through restricted stock vesting under a registered plan and payment was recorded as of that date. The filing indicates an approximate sale date of 09/15/2025 on the NYSE and states there were no other securities sold by the reporter in the past three months. The notice includes the seller's certification that they are unaware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine insider sale notice: 25,000 vested shares planned for sale, immaterial relative to shares outstanding.

The Form 144 documents a proposed sale by a person who received 25,000 common shares via restricted stock vesting on 11/04/2023. The broker is Morgan Stanley Smith Barney LLC and the planned sale date is approximately 09/15/2025 on the NYSE. At an aggregate market value of $614,250, the position represents roughly 0.08% of the reported 31,017,570 shares outstanding, which is immaterial from a share-supply perspective. There are no reported sales in the prior three months. This filing functions as a compliance disclosure under Rule 144 rather than signaling a material corporate event.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; includes vesting origin and seller's certification of no undisclosed material adverse information.

The notice specifies the securities were acquired through restricted stock vesting under a registered plan and identifies the acquisition and payment date as 11/04/2023. The filer attests they are not aware of undisclosed material adverse information, consistent with signature declarations on Form 144. The document contains no indications of trading plans or additional remarks. From a governance standpoint, the filing appears complete for its purpose and contains the standard representations required by the rule.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	614250.00	31017570	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/04/2023	Restricted stock vesting under a registered plan	Issuer			25000	11/04/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HRTG Form 144 report?

The filing reports a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $614,250.

When were the shares acquired and how?

The shares were acquired on 11/04/2023 via restricted stock vesting under a registered plan.

What is the approximate sale date and exchange listed on the filing?

The approximate date of sale is listed as 09/15/2025 and the sale is to occur on the NYSE.

How large is the proposed sale relative to outstanding shares?

The filing reports 31,017,570 shares outstanding; 25,000 shares equal roughly 0.08% of outstanding common stock.

Were any other securities sold by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.